first glp-1 approval Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies Translational GLP-1 science continues to

Turn the dose selector at the end of the pen until the window displays the .25 mg mark

For everyone else in the ecosystem generic manufacturers, biosimilar developers, hospital purchasing departments, pharmacy benefit managers, investors shorting or longing biotech positions a patent expiry is an opportunity

No statistically significant difference was detected in forced vital capacity (FVC) or self-sufficiency

Patients who did not take phentermine after discontinuing GLP-1 (N=34,668) Patients who started phentermine after discontinuing GLP-1 (N=7,773) Adapted with permission from Bartlet et al

Known under brand names Lomaira and Adipex-P, phentermine was the very first oral weight-loss medication approved by the FDA all the way back in 1959